Nosocomial Infections in Female Compared with Male Patients with Decompensated Liver Cirrhosis

Overview

Journal Sci Rep

Specialty Science

Date 2022 Mar 1

PMID 35228572

Authors

Marie Griemsmann

Tammo L Tergast

Nicolas Simon

Abdul-Rahman Kabbani

Michael P Manns

Heiner Wedemeyer

Markus Cornberg

Benjamin Maasoumy

Affiliations

Soon will be listed here.

Abstract

There are considerable differences between males and females regarding the etiology, progression and outcome of liver diseases. Infections are a frequent and severe complication in these patients. This study aimed to examine sex specific differences in the incidence and clinical course of nosocomial infections in patients with decompensated liver cirrhosis. A number of 556 consecutive hospitalized patients with decompensated liver cirrhosis and ascites were analyzed. The patients were followed up for the incidence of nosocomial infections, acute kidney injury (AKI), acute-on-chronic liver failure (ACLF) as well as liver transplantation and death (LTx-free survival). A number of 285 patients (111 women and 174 men) developed a nosocomial infection. Incidence was numerically lower in men (P = 0.076). While the frequency of a nosocomial spontaneous bacterial peritonitis was similar between males and females, the incidence of a nosocomial urinary tract infection was significantly higher in women (P < 0.001). No sex specific differences were documented regarding the outcome of an infection as indicated by a similar incidence of, AKI, ACLF as well as LTx-free survival. There seem to be no major differences in the incidence and outcome of nosocomial infections between male and female patients.

Citing Articles

Development and validation of prediction models for nosocomial infection and prognosis in hospitalized patients with cirrhosis.

Li S, Zhang Y, Lin Y, Zheng L, Fang K, Wu J Antimicrob Resist Infect Control. 2024; 13(1):85.

PMID: 39113159 PMC: 11304655. DOI: 10.1186/s13756-024-01444-y.

Acute decompensation of cirrhosis versus acute-on-chronic liver failure: What are the clinical implications?.

Xu M, Chen Y, Artru F United European Gastroenterol J. 2024; 12(2):194-202.

PMID: 38376886 PMC: 10954432. DOI: 10.1002/ueg2.12538.

References

Soldin O, Mattison D . Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009; 48(3):143-57. PMC: 3644551. DOI: 10.2165/00003088-200948030-00001. View

Ayyar V, DuBois D, Nakamura T, Almon R, Jusko W . Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression. J Pharmacol Exp Ther. 2019; 370(2):327-336. PMC: 7184193. DOI: 10.1124/jpet.119.257527. View

Regitz-Zagrosek V, Kararigas G . Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol Rev. 2016; 97(1):1-37. DOI: 10.1152/physrev.00021.2015. View

Pike C . Sex and the development of Alzheimer's disease. J Neurosci Res. 2016; 95(1-2):671-680. PMC: 5120614. DOI: 10.1002/jnr.23827. View

KAPLAN M . Primary biliary cirrhosis. N Engl J Med. 1996; 335(21):1570-80. DOI: 10.1056/NEJM199611213352107. View

Beland K, Lapierre P, Alvarez F . Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol. 2009; 15(9):1025-34. PMC: 2655185. DOI: 10.3748/wjg.15.1025. View

Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A . Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up. Eur J Gastroenterol Hepatol. 2016; 29(1):91-97. DOI: 10.1097/MEG.0000000000000747. View

Corrao G, Arico S, Zambon A, Torchio P, Di Orio F . Female sex and the risk of liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy. Scand J Gastroenterol. 1997; 32(11):1174-80. DOI: 10.3109/00365529709002999. View

Yokoyama Y, Nimura Y, Nagino M, Bland K, Chaudry I . Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res. 2005; 128(1):147-56. DOI: 10.1016/j.jss.2005.04.017. View

10.

Durazzo M, Belci P, Collo A, Prandi V, Pistone E, Martorana M . Gender specific medicine in liver diseases: a point of view. World J Gastroenterol. 2014; 20(9):2127-35. PMC: 3942817. DOI: 10.3748/wjg.v20.i9.2127. View

11.

Stroffolini T, Esvan R, Biliotti E, Sagnelli E, Gaeta G, Almasio P . Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease. J Med Virol. 2015; 87(11):1899-903. DOI: 10.1002/jmv.24243. View

12.

Shimizu I . Impact of oestrogens on the progression of liver disease. Liver Int. 2003; 23(1):63-9. DOI: 10.1034/j.1600-0676.2003.00811.x. View

13.

Moylan C, Brady C, Johnson J, Smith A, Tuttle-Newhall J, Muir A . Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008; 300(20):2371-8. PMC: 3640479. DOI: 10.1001/jama.2008.720. View

14.

Myers R, Shaheen A, Aspinall A, Quinn R, Burak K . Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2010; 54(3):462-70. DOI: 10.1016/j.jhep.2010.07.015. View

15.

OLeary J, Wong F, Reddy K, Garcia-Tsao G, Kamath P, Biggins S . Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience. Dig Dis Sci. 2016; 62(3):768-776. DOI: 10.1007/s10620-016-4416-7. View

16.

Mariante-Neto G, Marroni C, Fleck Junior A, Marroni C, Zanotelli M, Cantisani G . Impact of creatinine values on MELD scores in male and female candidates for liver transplantation. Ann Hepatol. 2013; 12(3):434-9. View

17.

Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N . Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study. Medicine (Baltimore). 2019; 98(6):e14475. PMC: 6380877. DOI: 10.1097/MD.0000000000014475. View

18.

Dionigi E, Garcovich M, Borzio M, Leandro G, Majumdar A, Tsami A . Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity. Am J Gastroenterol. 2017; 112(4):588-596. DOI: 10.1038/ajg.2017.19. View

19.

Arvaniti V, DAmico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010; 139(4):1246-56, 1256.e1-5. DOI: 10.1053/j.gastro.2010.06.019. View

20.

Merli M, Lucidi C, Pentassuglio I, Giannelli V, Giusto M, Di Gregorio V . Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. J Hepatol. 2013; 59(2):243-50. DOI: 10.1016/j.jhep.2013.03.012. View